Synapse - Nursing

Phase I and pharmacokinetic study of LY293111, an orally available small molecule known to be an LTB4 receptor antagonist, 5-lipoxygenase inhibitor and peroxisome proliferator activated receptor-gamma agonist (PPAR gamma)

Meeting Abstract

Budman, D. R.; Schwartz, G. K.; Endres, S.; Welch, M.; O'reilly, E.; Barile-Thiem, B.; Brail, L. H.; De Alwis, D. P.; Cleverly, A.; Weitzman, A.
European Journal of Cancer (2002)

Fulltext@MSK | Save

Stem cell transplantation (SCT) for the treatment of Fanconi anemia (FA) using a fludarabine (Flu) based cytoreductive regimen and T-cell depleted grafts from unrelated or mismatched related donors

Meeting Abstract

Boulad, F.; Auerbach, A. D.; Small, T. N.; Prasad, V.; Torok-Castanza, J.; Casson, A.; Duschock, B.; Collins, N.; Kernan, N. A.; O'Reilly, R. J.
Blood (2002)

Fulltext@MSK | Save

Phase II clinical experience with the proteasome inhibitor PS-341 in patients with indolent lymphomas

Meeting Abstract

O'Connor, O. A.; Moskowitz, C. H.; Wright, J. J.; Macgregor-Cortelli, B.; Straus, D.; Furst, D.; Horse-Grant, D.; Schenkein, D. P.; Zelenetz, A. D.
Blood (2002)

Fulltext@MSK | Save

An analysis of accelerated full course chemotherapy followed by upfront high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for patients with International Prognostic Index IV (IPI IV) aggressive NHL

Meeting Abstract

Moskowitz, C. H.; Kewalramani, T.; Donnelly, G.; Zelenetz, A. D.; Noy, A.; Rice, D.; Kuznetsov, M.; Straus, D.; Nimer, S. D.; Portlock, C. S.
Blood (2002)

Fulltext@MSK | Save

Intravenous busulfan and melphalan followed by an unmodified related or unrelated hematopoietic stem cell transplant for the treatment of advanced hematologic malignancies

Meeting Abstract

Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A. A.; Kernan, N. A.; Perales, M. A.; Prasad, V.; Young, J. W.; Van Den Brink, M.; Toomasi, F.; more...
Blood (2002)

Fulltext@MSK | Save